UBS Group AG - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,131,372
+71.2%
36,261
+119.6%
0.00%
+100.0%
Q2 2023$3,581,495
-22.0%
16,516
-34.6%
0.00%
-50.0%
Q1 2023$4,589,316
-4.2%
25,266
+3.6%
0.00%0.0%
Q4 2022$4,790,081
+67.7%
24,377
+91.9%
0.00%
+100.0%
Q3 2022$2,857,000
+127.3%
12,705
+27.8%
0.00%0.0%
Q2 2022$1,257,000
-66.9%
9,939
-66.9%
0.00%0.0%
Q1 2022$3,803,000
+1553.5%
30,000
+1606.5%
0.00%
Q4 2021$230,000
-92.1%
1,758
-92.6%
0.00%
-100.0%
Q3 2021$2,900,000
+4042.9%
23,707
+3780.0%
0.00%
Q2 2021$70,000
-88.3%
611
-87.8%
0.00%
Q1 2021$600,000
+733.3%
4,989
+608.7%
0.00%
Q4 2020$72,000
+18.0%
704
-9.7%
0.00%
Q3 2020$61,000
-77.5%
780
-67.8%
0.00%
Q2 2020$271,000
+81.9%
2,424
+17.8%
0.00%
Q1 2020$149,000
-33.2%
2,058
-30.5%
0.00%
Q4 2019$223,000
+291.2%
2,962
-15.3%
0.00%
Q3 2019$57,0003,4980.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders